Adjunctive analgesia with intravenous propacetamol does not reduce morphine-related adverse effects
|
|
- Madison Washington
- 6 years ago
- Views:
Transcription
1 British Journal of Anaesthesia 90 (3): 314±19 (2003) DOI: /bja/aeg076 Adjunctive analgesia with intravenous propacetamol does not reduce morphine-related adverse effects F. Aubrun 1 *, F. Kalfon 1, P. Mottet 1, A. Bellanger 2, O. Langeron 1, P. Coriat 1 and B. Riou 3 1 Department of Anaesthesiology and Critical Care, 2 Department of Pharmacy and 3 Department of Emergency Medicine and Surgery, Groupe Hospitalier PitieÂ-SalpeÃtrieÁre, Assistance Publique-HoÃpitaux de Paris (AP-HP), Universite Pierre et Marie Curie, Paris, France *Corresponding author: DeÂpartement d'anestheâsie-reâanimation, CHU PitieÂ-SalpeÃtrieÁre, 47 Boulevard de l'hoãpital, F Paris Cedex 13, France. frederic.aubrun@psl.ap-hop-paris.fr Background. Propacetamol is widely used in the management of postoperative pain. It decreases morphine requirements but its effect on the incidence of morphine-related adverse effects remains unknown. Methods. Patients (550) were randomly assigned to receive propacetamol or a placebo over the rst 24 h after operation in a blinded study. Intravenous morphine titration was performed, after which morphine was administered s.c. every 4 h according to their pain score. Pain was assessed using a visual analogue scale (VAS). The primary end-point was the incidence of morphine-related adverse effects. The main secondary end-points were morphine requirements and VAS score. Results. After morphine titration, the VAS score and the number of patients with pain relief did not differ between groups. Morphine requirements were decreased in the propacetamol group (21 vs 14.5 mg, P<0.001) but the incidence of morphine-related adverse effects did not differ between groups (42 vs 46%, not signi cant). In patients with moderate pain (n=395), morphine requirements decreased by 37% (P<0.001) and the percentage of patients requiring no morphine was greater (21 vs 8%, P=0.002) in the propacetamol group. In patients with severe pain (n=155), morphine requirements decreased by 18% (P=0.04) in the propacetamol group and the number of patients who did not require morphine (3 vs 8%) did not differ signi cantly. Conclusions. Although propacetamol induced a small morphine-sparing effect, it did not change the incidence of morphine-related adverse effects in the postoperative period. Moreover, no bene t could be demonstrated in patients with severe postoperative pain. Br J Anaesth 2003; 90: 314±19 Keywords: analgesics non-opioid, propacetamol; analgesics opioid, morphine; pain, postoperative Accepted for publication: October 17, 2002 Morphine is the most widely used drug to control postoperative pain; it is ef cacious but is associated with frequent adverse effects (nausea, vomiting, urine retention, pruritus and respiratory depression). Consequently, it has become very common to use non-opioid analgesics in association with morphine 1 to obtain a morphine sparingeffect and, hopefully, a decrease in morphine-related adverse effects. This concept is supported by several studies that emphasize the role of multimodal analgesia. 23 Numerous studies have demonstrated a morphine sparingeffect of several non-opioid analgesics, including propacetamol, 4±7 but signi cant decreases in morphinerelated adverse effects have been shown only for nonsteroid anti-in ammatory drugs (NSAIDs). 8 Propacetamol has become very popular in Europe. However, the i.v. form is relatively expensive. Ripouteau and colleagues 9 have recently reported reduced propacetamol costs by an early change from i.v. to oral acetaminophen. However, we considered that administration of propacetamol is not based on suf cient evidence as no study has yet demonstrated that propacetamol signi cantly decreases morphine-related adverse effects. Ó The Board of Management and Trustees of the British Journal of Anaesthesia 2003
2 Propacetamol and postoperative pain Therefore, we designed a prospective, randomized, blinded study of propacetamol in the postoperative period. In this study, in contrast to previous studies, the main endpoint was the incidence of morphine-related adverse effects and not morphine consumption only. Patients and methods The study was approved by an institutional review board (CCPPRB PitieÂ-SalpeÃtrieÁre, Paris, France) and all patients gave written informed consent. Enrolment began in April 1999 and ended in December Patients were eligible if they were aged 18 yr or older and were undergoing surgery in one of three units (each considered as a centre) of the Department of Anaesthesiology of PitieÂ-SalpeÃtrieÁre hospital (orthopaedic surgery, abdominal and general surgery, gynaecological surgery). Criteria for exclusion were as follows: age above 70 yr, ASA status III or IV, known allergy to propacetamol, emergency surgery. Patients with delirium or dementia, or who were not French speaking, were also excluded. Anaesthetists were asked to exclude patients who were expected to have no postoperative pain and those who were expected to have very severe postoperative pain requiring prolonged epidural and/or spinal postoperative analgesia or prolonged postoperative sedation and/or patient-controlled analgesia (PCA). Adjuvant postoperative regional anaesthesia, such as femoral nerve block, was authorized. The use of i.v. NSAIDs in the postoperative period was also authorized but not the use of other non-opioid analgesic drugs. Ketoprofen (50 mg i.v. every 6 h for 2 days; Profenid â ; Laboratoire Aventis, Paris, France) was used because it is the only i.v. NSAID available in France. 8 The use of clonidine was not authorized. During the preoperative visit, performed at least 48 h before surgery, the anaesthetist explained to the patient the protocol and the pain management, including the use of the visual analogue scale (VAS) score for pain. The expected postoperative pain was classi ed as moderate or severe according to the Consensus Conference of the SocieÂte FrancËaise d'anestheâsie et de ReÂanimation. 10 Moderate postoperative pain included pain which was expected to be moderate and to last less than 48 h, whereas severe postoperative pain included pain which was expected to be either severe (lasting less or more than 48 h) or moderate but to last more than 48 h. The study was a randomized, blinded, placebo-controlled trial. Randomization was strati ed according to centres. Patients were studied over the rst 24 h after operation and were assigned randomly to receive a placebo (saline 125 ml) or propacetamol (Pro-Dafalgan â ; Laboratoires UPSA, Rueil-Malmaison, France) in the postoperative period. Each vial was prepared immediately before administration by a nurse who was not involved in the care or pain assessment of the patient. Vials containing 2 g of propacetamol (yielding 1 g of acetaminophen) or saline were administered i.v. over 15 min. The rst administration was performed at the beginning of skin closure in the operating room. The dose regimen was propacetamol 2 g every 6 h. All nurses in the postanaesthesia care unit (PACU) and in the wards had been trained to assess pain using the VAS (0±100 mm, hand-held slide-rule type). 11 When patients had dif culty in manipulating the VAS, nurses were allowed to use a numerical rating scale (0±100 mm). 12 A strict protocol of i.v. morphine titration had been implemented in the PACU previously As soon as the patients were awake, they were questioned about the presence of pain (at least every 15 min) and asked to rate pain intensity. When the pain increased to more than 30 mm, i.v. morphine was given every 5 min in 3 mg increments (2 mg in patients weighing less than 60 kg). Pain relief was de ned as VAS less than 30 mm. Clinical monitoring included arterial blood pressure, heart rate, pulse oximetry (Sp O2 ), respiratory rate (RR) measurements, and sedation according to the Ramsay score. 13 When the patient was asleep (Ramsay score >2) no attempt was made at arousal, and the patient was considered as having adequate pain relief. Morphine titration was stopped if the patient had an RR lower than 10 bpm and/or a Sp O2 lower than 95%, and/or experienced a serious adverse event related to morphine administration (allergy, vomiting, severe pruritus). If there was severe ventilatory depression (RR less than 10 bpm), naloxone (i.v. bolus of 0.04 mg) was administered until RR was greater than 12 bpm. The decision for the patient to leave the PACU was taken by the anaesthetist after the nurse had checked that the patient ful lled the Aldrete criteria 14 and was not suffering from emesis, severe pain or major postoperative bleeding. Patients did not receive antiemetic prophylaxis. Postoperative nausea and vomiting were treated by the anaesthetist using metoclopramide 10±50 mg and ondansetron 4 mg in case of failure of high-dose metoclopramide. After i.v. morphine administration, the patients received morphine administration s.c. every 4 h, beginning as early as 2 h after the end of i.v. morphine titration either in the PACU or on the ward The dose of subcutaneous morphine was determined by a strict protocol based on the VAS at rest and the weight of the patient. Patients with pain relief (VAS less than 30 mm) did not receive morphine. Patients with a VAS between 30 and 60 mm received morphine at either 5 mg (<60 kg body weight) or 7.5 mg (>60 kg body weight); patients with VAS greater than 60 mm received either 7.5 mg (<60 kg body weight) or 10 mg (>60 kg body weight). The primary end-point of this study was the incidence of morphine-related adverse effects. The following adverse effects were noted over the study period: ventilatory depression de ned as a RR below 10 bpm and/or need for naloxone administration, nausea and vomiting, pruritus, retention of urine requiring drainage, bronchospasm and 315
3 Aubrun et al. Table 1 Patient characteristics. Data are mean (SD) [range], median (95% con dence interval) or number (%). No signi cant differences between groups. ² Only in patients receiving general anaesthesia Placebo Propacetamol Age (yr) 45 [18±72] 44 [18±85] Men 116 (42%) 126 (46%) Women 159 (58%) 149 (54%) Weight (kg) 68 (12) 69 (12) Type of surgery Orthopaedic 148 (54%) 145 (53%) Abdominal or pelvic 51 (19%) 54 (20%) Cervical 76 (28%) 76 (27%) Expected postoperative pain Moderate 196 (71%) 199 (72%) Severe 79 (29%) 76 (28%) Duration of surgery (min) 90 (80±90) 90 (85±90) Pre- and/or perioperative urine drainage 20 (7%) 16 (6%) ASA class I 185 (67%) 185 (67%) II 90 (33%) 90 (33%) Type of anaesthesia General 242 (88%) 247 (90%) Regional 32 (12%) 28 (10%) Both 1 (0.4%) 1 (0.4%) Dose of peroperative sufentanil (mg) ² 45 (18) 45 (24) cutaneous rash or other allergic events. Postoperative nausea and vomiting was graded on a three-item scale: minor (nausea only); moderate (vomiting either in the PACU or in the ward); severe (vomiting both in the PACU and in the ward). The secondary end-points were the total dose of morphine, the number of patients who did not receive morphine at all, VAS measurements, the number of patients with pain relief, and the satisfaction of the patient concerning pain management, using a numerical rating scale from 0 (worse) to 100 (best); satisfaction was de ned as a value of at least 80. All data were assessed retrospectively for potential minor protocol violations. These were classi ed as follows: error in a dose of i.v. or s.c. morphine (over- or underestimation) according to the weight and/or pain of the patient, error in administration of a dose of the study drug (cancelled or delayed), and administration of another non-opioid non- NSAID analgesic drug. Statistical analysis We assumed that morphine-related adverse effects would occur in 45% of patients in the placebo group. Using the Casagrande and Pike method, 17 we estimated that at least 265 patients would be needed in each group for the study to be able to detect a 30% difference (i.e. a decrease from 45 to 31%) with 90% certainty (1±b) and a two-sided 5% signi cance level (a). Therefore, we decided to include up to 550 patients, expecting a 5% drop-out rate. An intention-to-treat analysis was performed. Data are expressed as mean (SD) or median and 95% con dence interval (time delay, duration, morphine doses), unless speci ed otherwise. Student's t-test and repeated measures analysis of variance were used to compare means. The Mann±Whitney U-test was used to compare pairs of medians. Fisher's exact test was used for categorical variables. In a post hoc analysis, the subgroups of patients who were expected to experience severe postoperative pain and those expected to experience moderate postoperative pain were analysed separately. All comparisons were twotailed and a P value of less than 0.05 was required to rule out the null hypothesis. Statistical analysis was performed using NCSS 6.0 software (Statistical Solutions, Cork, Ireland). Results A total of 567 patients consented to participate at the preoperative anaesthesia visit and were randomly assigned to one of the two study groups. Seventeen (3%) patients were excluded because they did not undergo surgery (n=4), did not ful l the criteria for inclusion and exclusion (n=6), refused to participate in the study during the postoperative period (n=2), or experienced severe surgical postoperative complications (n=5). Thus, 550 patients were considered for analysis, 275 in the placebo group and 275 in the propacetamol group. The groups were well balanced with regard to patient characteristics, type and duration of surgery, expected postoperative pain, ASA status and type of anaesthesia (Table 1). The VAS measurement was signi cantly lower just before morphine titration in the PACU in the propacetamol group [44 (32) vs 50 (29) mm, P=0.02]. After morphine titration and during the whole study period, the VAS and the number of patients with pain relief did not differ signi cantly between the two groups. Morphine requirements were lower by 31% (21 vs 14.5 mg, P<0.001), the number of patients who did not require morphine at all was signi cantly greater (Table 2), and the percentage of satis ed patients was signi cantly greater (72 vs 61%, P<0.009) in the propacetamol group. However, the number of morphine-related adverse effects was not signi cantly different between the two groups (Table 2). When patients receiving an NSAID were excluded, the number of patients with morphine-related adverse effects was not signi cantly different between the two groups (44 vs 43%). Minor protocol violation occurred in 80 (15%) patients and there were no signi cant differences between the two groups. We performed a subgroup analysis according to the expected postoperative pain (moderate vs severe). Surgery was expected to induce moderate pain in 395 (72%) patients and severe pain in 155 (28%). In patients expected to experience severe pain, the duration of surgery was greater [135 (68) vs 87 (41) min, P<0.001], the perioperative dose of sufentanil was higher [56 (33) vs 41 (13) mg, P<0.001], the initial VAS was greater [57 (29) vs 43 (33) mm, P<0.001], the total postoperative dose of morphine was greater [29 (25.5±31.5) vs 14.5 (13±15) mg, P<0.001] and the percentage of patients requiring no morphine was lower 316
4 Propacetamol and postoperative pain Table 2 Postoperative variables and morphine-related adverse effects according to treatment. Data are mean (SD), median (95% con dence interval) or number (%). *P<0.05 vs placebo group. ² Number of patients with at least one adverse effect. One patient may have suffered several different adverse effects Placebo Propacetamol Dose of morphine (mg) I.V. titration 9 (9±9) 8 (6-9) Subcutaneous 10 (7.5±15) 7.5 (5±7.5)* Total 21 (16.5±24) 14.5 (12±16)* Patients receiving no morphine 17 (6%) 48 (17%)* Delay to titration in PACU (min) 35 (30±40) 35 (30±40) PACU duration (min) 160 (150±180) 150 (145±155) Titration stopped 5 (2%) 6 (2%) Postoperative NSAID 59 (21%) 54 (20%) Postoperative block 2 (1%) 4 (1%) Morphine adverse effects Nausea/vomiting 107 (39%) 94 (34%) Minor 38 (14%) 34 (12%) Moderate 56 (20%) 45 (16%) Severe 13 (5%) 15 (5%) Ventilatory depression 4 (1%) 4 (1%) Pruritus 2 (1%) 3 (1%) Urinary retention 27 (10%) 26 (10%) Allergy 1 (0.4%) 0 Total ² 127 (46%) 115 (42%) NSAID=non-steroidal anti-in ammatory drug. (8 vs 14%, P=0.002) compared with patients expected to experience moderate pain. In patients expected to experience severe pain (79 in the placebo group, 76 in the propacetamol group), morphine requirement was only 18% less in the propacetamol group [25.5 (28±35.5) vs 31 (28±35.5) mg, P=0.04]. The number of patients who did not require morphine (3 vs 8%) and the number of patients with morphine-related adverse effects (46 vs 56%) did not differ signi cantly between groups. Moreover, the VAS score and the number of patients with pain relief did not differ signi cantly between groups (Fig. 1). The percentage of satis ed patients was not signi cantly different between groups (56 vs 44%). In patients expected to experience moderate pain (196 in the placebo group, 199 in the propacetamol group), morphine requirements decreased by 37% in the propacetamol group [10 (8±13) mg vs 16 (15±18) mg, P<0.001]. The number of patients who did not require morphine (21 vs 8%, P<0.001) was signi cantly greater in the propacetamol group, whereas the number of patients with morphinerelated adverse effects (40 vs 42%) did not differ signi cantly between groups. The VAS score and the number of patients with complete pain relief were signi cantly lower in the propacetamol group (Fig. 2). The number of satis ed patients was signi cantly greater in the propacetamol group (76 vs 65%, P=0.03). Discussion In this study, we demonstrated that propacetamol did not decrease the incidence of morphine-related adverse effects Fig 1 Patients with expected severe postoperative pain. Comparison of (A) visual analogue pain scale (VAS; mean and 95% con dence interval) and (B) the percentage of patients with complete pain relief (VAS <30 mm) in the placebo (n=196) and propacetamol (n=199) groups. Pain relief was de ned as VAS <30 mm. VAS is the maximum value recorded just before morphine administration (I.V.=intravenous; S.C.= subcutaneous; every 4 h, from 1 to 6 doses). Ons=onset of morphine titration; End=end of morphine titration; PACU=postanaesthesia care unit; NS=not signi cant (between-group comparisons). during the rst 24 h after operation. Moreover, no bene t could be demonstrated in patients with severe postoperative pain. The protocol of i.v. morphine titration used in this study has been reported to provide rapid and reliable relief of postoperative pain The subcutaneous administration of morphine was authorized as soon as 2 h after morphine titration, as reported previously Subcutaneous morphine could be administered every 4 h and the dose was adjusted to the patient's pain. We did not use PCA, because, in our hospital, PCA is usually reserved for patients whose postoperative pain is expected to be very severe, and such patients were excluded from our study. However, a subcutaneous regimen of morphine is considered as ef cient as PCA, 18 provided the dose is adapted to the patient's pain. In the present study, administration of an NSAID was authorized because this type of drug is used routinely in our 317
5 Aubrun et al. Fig 2 Patients with expected moderate postoperative pain. Comparison of (A) visual analogue pain scale (VAS; mean and 95%con dence interval) and (B) the percentage of patients with pain relief (VAS <30 mm) in the placebo (n=79) and propacetamol (n=76) groups. Pain relief was de ned as VAS <30 mm. VAS is the maximum value recorded just before morphine administration (I.V.=intravenous; S.C.=subcutaneous, every 4 h, from 1 to 6 doses). P<0.001 between-group global comparison; *P<0.05 vs placebo group. Ons=onset of morphine titration; End=end of morphine titration; PACU=postanaesthesia care unit. practice. Since NSAIDs are thought to potentiate the analgesic effects of morphine, 19 they could have interfered with the effects of propacetamol, but the number of patients receiving NSAID was not signi cantly different between groups and exclusion of these patients did not modify our results. However, because the administration of NSAID was not randomized, our study does not enable us to explore the effect of propacetamol and NSAID coadministration. We con rmed that propacetamol induces a morphine sparing-effect (31%). We also observed that the degree of this effect depends on the intensity of postoperative pain: the value was 37% in patients with moderate postoperative pain vs 18% in patients with severe postoperative pain. The morphine-sparing effect of propacetamol has been reported as 46% after total hip replacement, 5 37% after knee ligamentoplasty 4 and 26% after vertebral disc surgery. 20 This morphine-sparing effect strongly suggests that the protocol was appropriately conducted and that it enabled us to observe the expected analgesic effect of propacetamol. However, in our opinion, such an effect cannot be a primary end-point per se, notably because of the low cost of morphine. Propacetamol failed to decrease morphine-related adverse effects. This result may suggest that the multimodal analgesia concept is erroneous, 1 at least when considering the adverse effects of morphine, and that clinical research should focus on the prevention and treatment of these adverse effects (mainly nausea and vomiting) rather than on the decrease of their incidence through a decrease in morphine requirements. A pharmacoeconomic approach of the problem of prevention and treatment of postoperative nausea and vomiting has been recently proposed and might be an appropriate solution. 21 Most of morphine-related adverse effects recorded in the present study were nausea and vomiting. Ventilatory depression occurred in only eight (1%) patients and severe ventilatory depression requiring naloxone administration was not observed. In contrast, urine retention occurred relatively frequently [53 (10%) patients]. Although the power of our study did not enable us to draw conclusions about the potential effects of propacetamol on the incidence of ventilatory depression and even urinary retention, it should be pointed out that no such trend towards an effect was observed. In patients with moderate postoperative pain, propacetamol was not devoid of clinically signi cant effects, although it did not signi cantly modify the incidence of morphinerelated adverse effects. Indeed, propacetamol increased the number of patients who did not require morphine at all, decreased the initial VAS score, improved pain relief (Fig. 2) and increased the patient's satisfaction. In contrast, in patients with severe postoperative pain we failed to demonstrate any bene t from the administration of propacetamol. Because of the large sample size of the present study, we suggest that administration of propacetamol in these patients is not helpful, notably because of its high cost. Our primary end-point was the incidence of morphinerelated adverse effects, and we must recognize that these adverse effects may be at least partly attributable to opioids given intraoperatively and not only to postoperative morphine, and that some of them, mainly nausea and vomiting, may also be because of factors other than opioid administration. 22 This does not alter our conclusion that propacetamol is not able to decrease signi cantly the occurrence of morphine-related adverse effects, but rather provides some explanation why the concept of multimodal analgesia failed in the postoperative period. Furthermore, our study did not include patients with very severe postoperative pain. However, the intensity of pain in these patients frequently required other techniques, including postoperative regional anaesthesia, to control pain. The poor results of propacetamol in our patients with severe pain compared with patients with moderate pain does not support its use in these clinical conditions. Also, the analgesic effect 318
6 Propacetamol and postoperative pain of propacetamol depends on the rate and amount of active drug reaching the central nervous system, and several authors have recently recommended the use of a loading dose and/or a larger dose of propacetamol to achieve therapeutic concentrations more rapidly and more completely However, larger doses may necessitate a caveat in patients with pre-existing renal and hepatic dysfunction 25 and those receiving microsomal cytochrome P450-inducing medications, 26 and it may induce platelet dysfunction. 27 Acknowledgements We thank David Baker (Department of Anaesthesiology, CHU Necker- Enfants Malades, Paris) for reviewing the manuscript. Other investigators who participated in the present study were D. Heitz, G. Daas, M. Dupuy (Department of Anaesthesiology) and E. Juhel (Department of Pharmacy), all at Groupe Hospitalier PitieÂ-SalpeÃtrieÁre, Paris, France. References 1 Dahl V, Raeder JC. Non-opioid postoperative analgesia. Acta Anaesthesiol Scand 2000; 44: 1191±203 2 Michaloliakou C, Chung F, Sharma S. Preoperative multimodal analgesia facilitates recovery after ambulatory laparoscopic cholecystectomy. Anesth Analg 1996; 82: 44±51 3 Brodner G, Pogatzki E, Van Aken H, et al. A multimodal approach to control postoperative pathophysiology and rehabilitation in patients undergoing abdominothoracic esophagectomy. Anesth Analg 1998; 86: 225±7 4 Delbos A, Boccard E. The morphine-sparing effect of propacetamol in orthopedic postoperative pain. J Pain Symptom Manage 1995; 10: 279±86 5 Peduto VA, Ballabio M, Stefanini S. Ef cacy of propacetamol in the treatment of postoperative pain. Morphine-sparing effect in orthopedic surgery. Italian Collaborative Group on Propacetamol. Acta Anaesthesiol Scand 1998; 42: 293±8 6 Cobby TF, Crighton IM, Kyriakides K, Hobbs GJ. Rectal paracetamol has a signi cant morphine-sparing effect after hysterectomy. Br J Anaesth 1999; 83: 253±6 7 Viel E, Langlade A, Osman M, Bilbault P, Eledjam JJ. Le propaceâtamol: des donneâes fondamentales aá l'utilisation clinique. Ann Fr Anesth ReÂanim 1999; 18: 332±40 8 Basto ER, Waintrop C, Mourey FD, Landru JP, Eurin BG, Jacob LP. Intravenous ketoprofen in thyroid and parathyroid surgery. Anesth Analg 2001; 92: 1052±7 9 Ripouteau C, Conort O, Lamas JP, Auleley GR, Hazebroucq G, Durieux P. Effect of multifaceted intervention promoting early switch from intravenous to oral acetaminophen for postoperative pain: controlled, prospective, before and after study. Br Med J 2000; 321: 1460±3 10 ConfeÂrence de Consensus. Prise en charge de la douleur postopeâratoire chez l'adulte et l'enfant. Ann Fr Anesth ReÂanim 1998; 17: 445±61 11 Huskisson EC. Measurement of pain. Lancet 1974; 9: 1127±31 12 Jensen MP, Karoly P, Braver S. The measurement of clinical pain intensity: a comparison of six methods. Pain 1986; 27: 117±26 13 Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974; 2: 656±9 14 Aldrete JA, Kroulik D. A postanesthetic recovery score. Anesth Analg 1970; 49: 924±34 15 Aubrun F, Monsel S, Langeron O, Coriat P, Riou B. Postoperative titration of intravenous morphine. Eur J Anaesthesiol 2001; 18: 159±65 16 Aubrun F, Monsel S, Langeron O, Coriat P, Riou B. Postoperative titration of intravenous morphine in the elderly. Anesthesiology 2002; 96: 17±23 17 Casagrande JT, Pike MC. An improved approximate formula for calculating sample sizes for comparing two binomial distributions. Biometrics 1978; 34: 483±6 18 ChoinieÁre M, Rittenhouse BE, Perreault S, et al. Ef cacy and costs of patient-controlled analgesia versus regularly administered intramuscular opioid therapy. Anesthesiology 1998; 89: 1377±88 19 Fletcher D, Benoist JM, Gautron M, Guilbaud G. Isobolographic analysis of interactions between intravenous morphine, propacetamol, and diclofenac in carageenin-injected rats. Anesthesiology 1997; 87: 317±26 20 Fletcher D, NeÁgre I, Barbin C, et al. Postoperative analgesia with i.v. propacetamol and ketoprofen combination after disc surgery. Can J Anaesth 1997; 44: 479±85 21 Hill RP, Lubarsky DA, Phillips-Bute B, et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology 2000; 92: 958±67 22 Apfel CC, LaÈaÈraÈ E, Koivuranta M, Greim CA, Roewer N. A simpli ed risk score for predicting postoperative nausea and vomiting: conclusions from cross-validation between two centers. Anesthesiology 1999; 91: 693± Schug SA, Sidebotham DA, McGuinnety M, Thomas J, Fox L. Acetaminophen as an adjunct to morphine by patient-controlled analgesia in the management of acute postoperative pain. Anesth Analg 1998; 87: 368±72 24 Heavner JE, Shi B, Diede J, Racz G. Acetaminophen (paracetamol) use and blood concentration in pain patients. Pain Digest 1996; 6: 215±18 25 Thummel KE, Slattery JT, Ro H, et al. Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults. Clin Pharmacol Ther 2000; 67: 591±9 26 Dong H, Haining RL, Thummel KE, Rettie AE, Nelson SD. Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen. Drug Metab Dispos 2000; 28: 1397± Niemi TT, Backman JT, SyrjaÈlaÈ MT, Viinakka LU, Rosenberg PH. Platelet dysfunction after intravenous ketorolac or propacetamol. Acta Anaesthesiol Scand 2000; 44: 69±74 319
British Journal of Anaesthesia 98 (1): (2007) doi: /bja/ael284 Advance Access publication October 25, 2006
British Journal of Anaesthesia 98 (1): 124 30 (2007) doi:10.1093/bja/ael284 Advance Access publication October 25, 2006 PAIN Effects of a loading dose of morphine before i.v. morphine titration for postoperative
More informationBritish Journal of Anaesthesia 94 (3): (2005) doi: /bja/aei056 Advance Access publication December 24, 2004
British Journal of Anaesthesia 94 (3): 347 51 (2005) doi:10.1093/bja/aei056 Advance Access publication December 24, 2004 PAIN The preoperative administration of ketoprofen improves analgesia after laparoscopic
More informationSatisfactory Analgesia Minimal Emesis in Day Surgeries. (SAME-Day study) A Randomized Control Trial Comparing Morphine and Hydromorphone
Satisfactory Analgesia Minimal Emesis in Day Surgeries (SAME-Day study) A Randomized Control Trial Comparing Morphine and Hydromorphone HARSHA SHANTHANNA ASSISTANT PROFESSOR ANESTHESIOLOGY MCMASTER UNIVERSITY
More informationShow Me the Evidence: Epidurals, PVBs, TAP Blocks Christopher L. Wu, MD Professor of Anesthesiology The Johns Hopkins Hospital
Show Me the Evidence: Epidurals, PVBs, TAP Blocks Christopher L. Wu, MD Professor of Anesthesiology The Johns Hopkins Hospital Overview Review overall (ERAS and non-eras) data for EA, PVB, TAP Examine
More informationSafe IV Opioid Titration in Patients With Severe Acute Pain
PAIN CARE Safe IV Opioid Titration in Patients With Severe Acute Pain Chris Pasero, MS, RN-BC, FAAN PROVIDING EFFECTIVE PAIN control while minimizing opioid-induced adverse effects in patients with severe
More informationBalanced Analgesia With NSAIDS and Coxibs. Raymond S. Sinatra MD, Ph.D
Balanced Analgesia With NSAIDS and Coxibs Raymond S. Sinatra MD, Ph.D Prostaglandins and Pain The primary noxious mediator released from damaged tissue is prostaglandin (PG) PG is responsible for nociceptor
More informationKetoprofen, diclofenac or ketorolac for pain after tonsillectomy in adults?
British Journal of Anaesthesia 82 (1): 56 60 (1999) Ketoprofen, diclofenac or ketorolac for pain after tonsillectomy in adults? P. Tarkkila* and L. Saarnivaara Department of Anaesthesia, Otolaryngological
More informationAntiemetic and analgesic-sparing effects of diphenhydramine added to morphine intravenous patient-controlled analgesia
British Journal of Anaesthesia 94 (6): 835 9 (2005) doi:10.1093/bja/aei137 Advance Access publication April 15, 2005 Antiemetic and analgesic-sparing effects of diphenhydramine added to morphine intravenous
More informationDroperidol has comparable clinical efficacy against both nausea and vomiting
British Journal of Anaesthesia 103 (3): 359 63 (2009) doi:10.1093/bja/aep177 Advance Access publication July 15, 2009 has comparable clinical efficacy against both nausea and vomiting C. C. Apfel 1 *,
More informationMr David A McDonald Service Improvement Manager Whole System patient Flow Improvement Programme Scottish Government
Mr David A McDonald Service Improvement Manager Whole System patient Flow Improvement Programme Scottish Government Introduction Brief update Two main topics Use of Gabapentin Local Infiltration Analgesia
More informationAlizaprideand ondansetronin the prevention of postoperative nausea and vomiting: a prospective, randomized, double-blind, placebocontrolled
Alizaprideand ondansetronin the prevention of postoperative nausea and vomiting: a prospective, randomized, double-blind, placebocontrolled trial. M. Smets N. Van Langenhove G. Dewinter Vrijdagochtendkrans22
More informationSufentanil Sublingual Tablet System 15mcg vs IV PCA Morphine: A Comparative Analysis of Patient Satisfaction and Drug Utilization by Surgery Type
Sufentanil Sublingual Tablet System 15mcg vs IV PCA Morphine: A Comparative Analysis of Patient Satisfaction and Drug Utilization by Surgery Type 2016 European Society of Regional Anesthesia Congress Maastricht,
More informationEffective pain management begins with OFIRMEV (acetaminophen) injection FIRST Proven efficacy with rapid reduction in pain 1
Effective pain management begins with OFIRMEV (acetaminophen) injection FIRST Proven efficacy with rapid reduction in pain 1 Fast onset of pain relief with 7% reduction in visual analog scale (VAS) scores
More informationResearch and Reviews: Journal of Medical and Health Sciences
Research and Reviews: Journal of Medical and Health Sciences Comparison of Paracetamol infusion with Diclofenac infusion for perioperative analgesia. Yoganarasimha N*, Raghavendra TR, Radha MK, Amitha
More informationIntrathecal sufentanil and morphine for post-thoracotomy pain
British Journal of Anaesthesia 86 (2): 236±40 (2001) Intrathecal sufentanil and morphine for post-thoracotomy pain relief ² N. Mason, R. Gondret, A. Junca and F. Bonnet * Service d'anestheâsie-reâanimation,
More informationNefopam after total hip arthroplasty: Role in multimodal analgesia
Orthopaedics & Traumatology: Surgery & Research (2013) 99, 169 174 Available online at www.sciencedirect.com ORIGINAL ARTICLE Nefopam after total hip arthroplasty: Role in multimodal analgesia F. Remérand
More informationEffects of intraoperative i.v. acetaminophen vs i.m. meperidine on post-tonsillectomy pain in children
British Journal of Anaesthesia 96 (6): 790 5 (2006) doi:10.1093/bja/ael084 Advance Access publication April 13, 2006 Effects of intraoperative i.v. acetaminophen vs i.m. meperidine on post-tonsillectomy
More informationEffect of Ketorolac on Pain Scores and Length of Stay in Post Anaesthetic Care Unit after Major Abdominal Surgery
Effect of Ketorolac on Pain Scores and Length of Stay in Post Anaesthetic Care Unit after Major Abdominal Surgery Amanat Khan, Ghulam Sabir Iqbal, Azra Naseem, Mohammad Usman Ahmed, Omer Salahuddin Department
More informationEvaluation of a single preoperative dose of pregabalin for attenuation of postoperative pain after laparoscopic cholecystectomy
British Journal of Anaesthesia 101 (5): 700 4 (2008) doi:10.1093/bja/aen244 Advance Access publication August 20, 2008 Evaluation of a single preoperative dose of pregabalin for attenuation of postoperative
More informationMedicines Q&As. Medicines Q&As. What is the evidence to support the use of IV paracetamol for the treatment of pain? Background.
Medicines Q&As Q&A 361.1 What is the evidence to support the use of IV paracetamol for the treatment of pain? Background Prepared by UK Medicines Information (UKMi) pharmacists for NHS healthcare professionals
More informationResearch and Reviews: Journal of Medical and Health Sciences
Research and Reviews: Journal of Medical and Health Sciences Evaluation of Epidural Clonidine for Postoperative Pain Relief. Mukesh I Shukla, Ajay Rathod, Swathi N*, Jayesh Kamat, Pramod Sarwa, and Vishal
More informationThe incidence of moderate to severe pain (SP) with
Pain Medicine Section Editor: Spencer S. Liu Predictive Factors of Severe Postoperative Pain in the Postanesthesia Care Unit Frédéric Aubrun, MD, PhD* Nathalie Valade, MD* Pierre Coriat, MD* Bruno Riou,
More informationSenior Visceral Surgery Fast-Track in Colorectal Surgery The anesthetist s point of view
Senior Visceral Surgery Fast-Track in Colorectal Surgery The anesthetist s point of view 1st Geneva International SCIENTIFIC DAY February 3 rd 2010 E. Schiffer Dept APSI, HUG 1 Fast-Track in colorectal
More informationEvaluation of postural stability after low-dose droperidol in outpatients undergoing gynaecological dilatation and curettage procedure
British Journal of Anaesthesia 88 (6): 819±23 (2002) Evaluation of postural stability after low-dose droperidol in outpatients undergoing gynaecological dilatation and curettage procedure D. Song, F. Chung*,
More informationRandomized prospective study of the analgesic effect of nefopam after orthopaedic surgery ²
British Journal of Anaesthesia 91 (6): 836±41 (2003) DOI: 10.1093/bja/aeg264 Randomized prospective study of the analgesic effect of nefopam after orthopaedic surgery ² B. Du Manoir 1, F. Aubrun 2, M.
More informationThe effect of duration of dose delivery with patient-controlled analgesia on the incidence of nausea and vomiting after hysterectomy
Br J Clin Pharmacol 1998; 45: 57 62 The effect of duration of dose delivery with patient-controlled analgesia on the incidence of nausea and vomiting after hysterectomy Annie Woodhouse* & Laurence E. Mather
More informationPost Caesarean Analgesia An Update. Kim Ekelund MD, PhD, associate professor Rigshospitalet Copenhagen, Denmark
Post Caesarean Analgesia An Update Kim Ekelund MD, PhD, associate professor Rigshospitalet Copenhagen, Denmark Post caesarean analgesia No Conflicts of Interests Neuraxial opioids Multimodal therapy Plan
More informationDigital RIC. Rhode Island College. Linda M. Green Rhode Island College
Rhode Island College Digital Commons @ RIC Master's Theses, Dissertations, Graduate Research and Major Papers Overview Master's Theses, Dissertations, Graduate Research and Major Papers 1-1-2013 The Relationship
More informationEfficacy of Prophylactic Ondansetron in a Patient-controlled Analgesia Environment
The Journal of International Medical Research 2004; 32: 160 165 Efficacy of Prophylactic Ondansetron in a Patient-controlled Analgesia Environment SH HAN, YJ LIM, YJ RO, SC LEE, YS PARK AND YC KIM Department
More informationIntravenous lidocaine infusions. Dr Ian McConachie FRCA FRCPC
Intravenous lidocaine infusions Dr Ian McConachie FRCA FRCPC Thank the organisers for inviting me. No conflicts or disclosures Lidocaine 1 st amide local anesthetic Synthesized in 1943 by Lofgren in Sweden.
More informationDEXAMETHASONE WITH EITHER GRANISETRON OR ONDANSETRON FOR POSTOPERATIVE NAUSEA AND VOMITING IN LAPAROSCOPIC SURGERY
DEXAMETHASONE WITH EITHER GRANISETRON OR ONDANSETRON FOR POSTOPERATIVE NAUSEA AND VOMITING IN LAPAROSCOPIC SURGERY Alia S. Dabbous *, Samar I. Jabbour-Khoury **, Viviane G Nasr ***, Adib A Moussa ***,
More informationAs laparoscopic surgeries are gaining popularity, Original Article. Maharjan SK 1, Shrestha S 2 1. Introduction
, Vol. 1, No. 1, Issue 1, Jul.-Sep., 2012 Original Article Maharjan SK 1, Shrestha S 2 1 Associate Professor, 2 Assistant Professor, Department of Anaesthesiology and Intensive Care Kathmandu Medical College,
More informationRectal and parenteral paracetamol, and paracetamol in combination with NSAIDs, for postoperative analgesia
British Journal of Anaesthesia 88 (2): 215±26 (2002) Rectal and parenteral paracetamol, and paracetamol in combination with NSAIDs, for postoperative analgesia J. Rùmsing 1*, S. Mùiniche 2 and J. B. Dahl
More informationThe Influence of Bilateral Superficial Cervical Plexuses Block (BSCBs) as Pre-emptive Analgesia on Patient Satisfaction after Thyroid Surgery
11 The Influence of Bilateral Superficial Cervical Plexuses Block (BSCBs) as Pre-emptive Analgesia on Patient Satisfaction after Thyroid Surgery Hisham Negmi MD*, Ashraf Moustafa MD*, Mohamed Rabie MD*,
More informationEmetic effects of morphine and piritramide ²
British Journal of Anaesthesia 91 (2): 218±23 (2003) DOI: 10.1093/bja/aeg165 Emetic effects of morphine and piritramide ² C. Breitfeld 1, J. Peters 1 *, T. Vockel 1, C. Lorenz 2 and M. Eikermann 1 1 Klinik
More informationGuidelines on the Safe Practice of Acute Pain Management
Page 1 of 7 Guidelines on the Safe Practice of Acute Pain Version Effective Date 1 1 MAY 1994 (Reviewed Feb 2002) 2 1 DEC 2014 Document No. HKCA P11 v2 Prepared by College Guidelines Committee Endorsed
More informationJSLS. Analgesia Following Major Gynecological Laparoscopic Surgery - PCA versus Intermittent Intramuscular Injection
Analgesia Following Major Gynecological Laparoscopic Surgery - PCA versus Intermittent Intramuscular Injection David M. B. Rosen, Alan M. Lam, Mark A. Carlton, Gregory M. Cario, Lindsay McBride 3 JSLS
More informationPharmacist Educational Intervention in Intravenous Patient-Controlled Analgesia is Associated with Decreased Postoperative Pain
Research & Reviews: Journal of Hospital and Clinical Pharmacy Pharmacist Educational Intervention in Intravenous Patient-Controlled Analgesia is Associated with Decreased Postoperative Pain Ikkou Hirata
More informationPostoperative epidural analgesia using local anesthetic
REGIONAL ANESTHESIA SECTION EDITOR DENISE J. WEDEL A Comparison of 0.1% and 0.2% Ropivacaine and Bupivacaine Combined with Morphine for Postoperative Patient-Controlled Epidural Analgesia After Major Abdominal
More informationMorphine for post-caesarean section analgesia: intrathecal, epidural or intravenous?
O r i g i n a l A r t i c l e Singapore Med J 2005; 46(8) : 392 Morphine for post-caesarean section analgesia: intrathecal, epidural or intravenous? Y Lim, S Jha, A T Sia, N Rawal ABSTRACT Introduction:
More informationAnaesthesia and Pain Management for Endo Exo Femoral Prosthesis (EEFP) Bridging the Gap from Surgery to Rehabilitation
Anaesthesia and Pain Management for Endo Exo Femoral Prosthesis (EEFP) Bridging the Gap from Surgery to Rehabilitation Dr Ajay Kumar Senior Lecturer Macquarie and Melbourne University Introduction Amputee
More informationDORIS DUKE MEDICAL STUDENTS JOURNAL Volume V,
Continuous Femoral Perineural Infusion (CFPI) Using Ropivacaine after Total Knee Arthroplasty and its Effect on Postoperative Pain and Early Functional Outcomes Eric Lloyd Scientific abstract Total Knee
More informationDexamethasone combined with other antiemetics for prophylaxis after laparoscopic cholecystectomy
Original Research Article Dexamethasone combined with other antiemetics for prophylaxis after laparoscopic cholecystectomy T. Uma Maheswara Rao * Associate Professor, Department of Surgery, Konaseema Institute
More informationCurrent evidence in acute pain management. Jeremy Cashman
Current evidence in acute pain management Jeremy Cashman Optimal analgesia Best possible pain relief Lowest incidence of side effects Optimal analgesia Best possible pain relief Lowest incidence of side
More informationParecoxib, Celecoxib and Paracetamol for Post Caesarean Analgesia: A Randomised Controlled Trial
Parecoxib, Celecoxib and Paracetamol for Post Caesarean Analgesia: A Randomised Controlled Trial McDonnell NJ, Paech MJ, Baber C, Nathan E Clinical Associate Professor Nolan McDonnell School of Medicine
More informationHow to manage severe postoperative pain? Pr Patricia Lavand homme Anesthesiology Dpt & Acute Pain Service Brussels, Belgium
How to manage severe postoperative pain? Pr Patricia Lavand homme Anesthesiology Dpt & Acute Pain Service Brussels, Belgium No conflict of interest to declare. Does severe acute postoperative pain still
More informationAcute postoperative pain management continues
Hosp Pharm 2014;49(11):1022 1032 2014 Thomas Land Publishers, Inc. www.hospital-pharmacy.com doi: 10.1310/hpj4911-1022 Original Article Impact of Intraoperative Acetaminophen Administration on Postoperative
More informationScottish Medicines Consortium
Scottish Medicines Consortium extended release epidural morphine, 10mg/ml (10mg, 15mg and 20mg) (Depodur ) No. (528/09) Flynn Pharma Ltd 09 January 2009 The Scottish Medicines Consortium (SMC) has completed
More informationA comparison of Ketoprofen and Diclofenac for acute musculoskeletal pain relief: a prospective randomised clinical trial
Hong Kong Journal of Emergency Medicine A comparison of Ketoprofen and Diclofenac for acute musculoskeletal pain relief: a prospective randomised clinical trial P Ng, CW Kam, HH Yau Objectives: To compare
More informationPerspectives in Clinical Research Volume 4 Issue 2 April-June 2013 Pages Vol 4 / Issue 2 / Apr-Jun 2013
Perspectives in Clinical Research Volume 4 Issue 2 April-June 2013 Pages 115-154 Vol 4 / Issue 2 / Apr-Jun 2013 Original Article Godrat Akhavanakbari, Masood Entezariasl, Khatereh Isazadehfar, Fariba Kahnamoyiagdam
More informationI ve Got You Under My Skin: A Comparison of IV and s/c PCA. Nick Williamson Clinical Nurse Specialist
I ve Got You Under My Skin: A Comparison of IV and s/c PCA Nick Williamson Clinical Nurse Specialist How did PCA get under my skin? Started in 2009 when I started working at KCH Subcut PCA!!! PCA refers
More informationCAESAREAN SECTION Brian Fredman
CHAPTER 3 GYNAECOLOGICAL SURGERY CAESAREAN SECTION Brian Fredman Review of evidence: surgical site infusion Of the seven studies on surgical site local anaesthetic infusion after Caesarean section performed
More informationGabapentin Does Not Improve Analgesia Outcomes For Total Joint Replacement. Manyat Nantha-Aree, MD
Gabapentin Does Not Improve Analgesia Outcomes For Total Joint Replacement Manyat Nantha-Aree, MD Objective n Preliminary results of MOBILE study in total hip and knee arthroplasty Background n Gabapentin=
More informationOFIRMEV a non-opioid, non-nsaid, intravenous analgesic for the management of pain
FOR PHARMACY PROFESSIONALS In pharmacokinetic studies Rapid time to reach Cmax with IV acetaminophen OFIRMEV from the start OFIRMEV g demonstrated early and high Cmax at minutes Consider administering
More informationIntroducttion. Sweety Rana 1, SP Singh 1, M Asad 1, V Bakshi 2
doi:10.17659/01.2018.0018 Journal of Case Reports 2018;8(1):67-71 Comparative Evaluation of the Efficacy of Intrathecal Fentanyl, Clonidine and Fentanyl-Clonidine Combination as an Adjuvant to Bupivacaine
More informationPerioperative Pain Management
Perioperative Pain Management Overview and Update As defined by the Anesthesiologist's Task Force on Acute Pain Management are from the practice guidelines from the American Society of Anesthesiologists
More informationAlessandro Di Filippo Manuela Magherini Peggy Ruggiano Antonio Ciardullo Silvia Falsini
DOI 10.1007/s40520-014-0272-5 ORIGINAL ARTICLE Postoperative analgesia in patients older than 75 years undergoing intervention for per-trochanteric hip fracture: a single centre retrospective cohort study
More informationEfficacy of a single-dose ondansetron for preventing post-operative nausea and vomiting
European Review for Medical and Pharmacological Sciences 2001; 5: 59-63 Efficacy of a single-dose ondansetron for preventing post-operative nausea and vomiting after laparoscopic cholecystectomy with sevoflurane
More informationAudits. An Audit of Intrathecal Morphine Analgesia for Non- Obstetric Postsurgical Patients in an Adult Tertiary Hospital P. C. LIM*, P. E.
Anaesth Intensive Care 2006; 34: 776-781 Audits An Audit of Intrathecal Morphine Analgesia for Non- Obstetric Postsurgical Patients in an Adult Tertiary Hospital P. C. LIM*, P. E. MACINTYRE Department
More informationEfficacy of palonosetron for the prevention of postoperative nausea and vomiting: a randomized, double-blinded, placebo-controlled trial
British Journal of Anaesthesia 112 (3): 485 90 (2014) Advance Access publication 22 October 2013. doi:10.1093/bja/aet340 CLINICAL PRACTICE Efficacy of palonosetron for the prevention of postoperative nausea
More informationSupplemental oxygen does not reduce postoperative nausea and vomiting after thyroidectomy ²
British Journal of Anaesthesia 91 (6): 857±61 (2003) DOI: 10.1093/bja/aeg267 Supplemental oxygen does not reduce postoperative nausea and vomiting after thyroidectomy ² J. L. Joris 1 *, N. J. Poth 1, A.
More informationContinuous Wound Infusion and Postoperative Pain Current status?
Continuous Wound Infusion and Postoperative Pain Current status? Pr Patricia Lavand homme Department of Anesthesiology St Luc Hospital University Catholic of Louvain Medical School Brussels, Belgium Severe
More informationTHE FIRST YEAR'S EXPERIENCE OF AN ACUTE PAIN SERVICE
British Journal of Anaesthesia 1991; 67: 353-359 THE FIRST YEAR'S EXPERIENCE OF AN ACUTE PAIN SERVICE R. G. WHEATLEY, T. H. MADEJ, I. J. B. JACKSON AND D. HUNTER SUMMARY The benefits, risks and resource
More informationThe intensity of preoperative pain is directly correlated with the amount of morphine needed for postoperative analgesia
The intensity of preoperative pain is directly correlated with the amount of morphine needed for postoperative analgesia This study has been published: The intensity of preoperative pain is directly correlated
More informationUpdate Update on Anaesthesia for c-section Dr Kerry Litchfield Consultant Anaesthetist Princess Royal Maternity Glasgow, Scotland
Update Update on Anaesthesia for c-section Dr Kerry Litchfield Consultant Anaesthetist Princess Royal Maternity Glasgow, Scotland Caesarean section is the most common surgical procedure in the world 1
More informationA Randomized Trial Comparing the Safety and Efficacy of Intravenous Ibuprofen versus Ibuprofen and Acetaminophen in Knee or Hip Arthroplasty
Pain Physician 2016; 19:349-356 ISSN 1533-3159 Randomized Trial A Randomized Trial Comparing the Safety and Efficacy of Intravenous Ibuprofen versus Ibuprofen and Acetaminophen in Knee or Hip Arthroplasty
More informationTHE EFFECTS OF PREOPERATIVE PREGABALIN ON POSTOPERATIVE ANALGESIA AND MORPHI- NE CONSUMPTION AFTER ABDOMINAL HYSTERECTOMY
Acta Medica Mediterranea, 2014, 30: 481 THE EFFECTS OF PREOPERATIVE PREGABALIN ON POSTOPERATIVE ANALGESIA AND MORPHI- NE CONSUMPTION AFTER ABDOMINAL HYSTERECTOMY ALI EMAN 1, AYTEN BILIR 2, SERBÜLENT GÖKHAN
More informationENHANCED RECOVERY PROTOCOLS FOR KNEE REPLACEMENT
ENHANCED RECOVERY PROTOCOLS FOR KNEE REPLACEMENT Jeff Gadsden, MD, FRCPC, FANZCA Associate Professor Duke University Department of Anesthesiology Regional Anesthesia and Acute Pain Medicine DISCLOSURES
More informationResults of a one-year, retrospective medication use evaluation. Joseph Ladd, PharmD PGY-1 Pharmacy Resident BHSF Homestead Hospital
Results of a one-year, retrospective medication use evaluation Joseph Ladd, PharmD PGY-1 Pharmacy Resident BHSF Homestead Hospital Briefly review ketamine s history, mechanism of action, and unique properties
More informationPost-operative Analgesia for Caesarean Section
Post-operative Analgesia for Caesarean Section Introduction Good quality analgesia after any surgery leads to earlier mobilisation, fewer pulmonary and cardiac complications, a reduced risk of DVT and
More informationEfficacy and Safety of Sublingual Sufentanil 30 mcg for the Management of Acute Pain Following Ambulatory Surgery. Pamela P.
Efficacy and Safety of Sublingual Sufentanil 30 mcg for the Management of Acute Pain Following Ambulatory Surgery Pamela P. Palmer, MD, PhD Disclosures for Dr. Pamela Palmer AcelRx employee Currently own
More informationInternational Journal of Drug Delivery 5 (2013) Original Research Article
International Journal of Drug Delivery 5 (2013) 239-244 http://www.arjournals.org/index.php/ijdd/index Original Research Article ISSN: 0975-0215 Comparative study of duration of analgesia with epidural
More informationEfficacy of scheduled time ketorolac administration compared to continuous infusion for post-operative pain after abdominal surgery
European Review for Medical and Pharmacological Sciences Efficacy of scheduled time ketorolac administration compared to continuous infusion for post-operative pain after abdominal surgery A. RUSSO 1,
More informationIs Local Infiltration Analgesia (LIA) a Safe and Effective Method for Post-Operative Pain Management After a Unilateral Total Knee Arthroplasty (TKA)?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2013 Is Local Infiltration Analgesia (LIA)
More informationVolatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design
British Journal of Anaesthesia 88 (5): 659±68 (2002) Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design C. C.
More informationComparison of Drugs and Intravenous Crystalloid in Reduction of Postoperative Nausea and Vomiting after Laparoscopic Surgery
Comparison of Drugs and World Intravenous Journal of Crystalloid Laparoscopic in Reduction Surgery, of January-April Postoperative 2008;1(1):29-34 Nausea and Vomiting after Lap Surgery Comparison of Drugs
More informationPelin Cengiz, Derya Gokcinar, Isil Karabeyoglu, Hulya Topcu, Gizem Selen Cicek and Nermin Gogus
ORIGINAL ARTICLE Intraoperative Low-Dose Ketamine Infusion Reduces Acute Postoperative Pain Following Total Knee Replacement Surgery: A Prospective, Randomized Double-Blind Placebo-Controlled Trial Pelin
More informationIJMDS January 2017; 6(1) Dr Robina Makker Associate professor 2 Dr Amit Bhardwaj
Original Article Comparative efficacy of ondansetron versus granisetron to prevent perioperative nausea and vomiting in patients undergoing gynaecological surgery under spinal anaesthesia Makker R 1, Bhardwaj
More informationManagement of post-strabismus nausea and vomiting in children using ondansetron: a value-based comparison of outcomes 1^
British Journal of Anaesthesia 89 (3): 473-8 (2002) Management of post-strabismus nausea and vomiting in children using ondansetron: a value-based comparison of outcomes 1^ B. Sennaraj 1, D. Shende 1,
More informationIntra-articular Adjuvant Analgesics Following Knee Arthroscopy: Comparison between Dexmedetomidine and Fentanyl
Intra-articular Adjuvant Analgesics Following Knee Arthroscopy: Comparison between Dexmedetomidine and Fentanyl 1 Mostafa El-Hamamsy, 2 Mohsen Dorgham 1 Anaesthesia Dept., Faculty of Medicine, El-Fayoum
More informationAnesthesia for Total Hip and Knee Arthroplasty
Anesthesia for Total Hip and Knee Arthroplasty Typical approach Describe anesthesia technique Rather Describe issues with THA and TKA How anesthesia can modify Issues Total Hip Total Knee Blood Loss ++
More informationAssociate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008
Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008 PAIN MECHANISMS Somatic Nociceptive Visceral Inflammatory response sensitizes
More informationEfficacy of postoperative epidural analgesia Block B M, Liu S S, Rowlingson A J, Cowan A R, Cowan J A, Wu C L
Efficacy of postoperative epidural analgesia Block B M, Liu S S, Rowlingson A J, Cowan A R, Cowan J A, Wu C L CRD summary This review evaluated the efficacy of post-operative epidural analgesia. The authors
More informationLabor Epidural: Local Anesthetics and Beyond
Goals: Labor Epidural: Local Anesthetics and Beyond Pedram Aleshi MD The Changing Practice of Anesthesia September 2012 Review Concept of MLAC Local anesthetic efficacy Local anesthetic sparing effects:
More information4/18/2018. Disclosure. Learning Objectives. St. Vincent Healthcare. Supportive Literature. Background
Implementation of a risk-score-dependent antiemetic protocol to reduce post-operative nausea and vomiting (PONV) in inpatient surgical patients Eugene P. Eldridge, PharmD, RPh PGY-1 Pharmacy Resident St.
More informationEffect of Pre-Incisional Continuous Regional Block on Early and Late Postoperative Conditions in Tibial Osteotomy and Total Knee Arthroplasty
22 The Open Orthopaedics Journal, 2009, 3, 22-26 Open Access Effect of Pre-Incisional Continuous Regional Block on Early and Late Postoperative Conditions in Tibial Osteotomy and Total Knee Arthroplasty
More informationA.B. OZER, O.L. ERHAN, E. KELES*, I. DEMIREL, A. BESTAS, G. GUNDUZ
European Review for Medical and Pharmacological Sciences Comparison of the effects of preoperative and intraoperative intravenous application of dexketoprofen on postoperative analgesia in septorhinoplasty
More informationEffects of analgesia methods on serum IL-6 and IL-10 levels after cesarean delivery
Effects of analgesia methods on serum IL-6 and IL-10 levels after cesarean delivery Z.-M. Xing*, Z.-Q. Zhang*, W.-S. Zhang and Y.-F. Liu Anesthesia Department, No. 1 People s Hospital of Shunde, Foshan,
More informationImproved acute pain management starts here 1
Improved acute pain management starts here 1 Indication OFIRMEV is indicated for the management of mild to moderate pain; the management of moderate to severe pain with adjunctive opioid analgesics; and
More informationRegional anaesthesia in paediatric day case surgery. PA Lönnqvist Karolinska Institutet Karolinska University Hospital Stockholm, Sweden
Regional anaesthesia in paediatric day case surgery PA Lönnqvist Karolinska Institutet Karolinska University Hospital Stockholm, Sweden Ambulatory surgery in children Out-patient surgery in children did
More informationMalaysian Orthopaedic Journal 2008 Vol 2 No 2
Randomized Clinical Trial of Periarticular Drug Injection used in combination Patient-Controlled Analgesia versus Patient-Controlled Analgesia Alone in Total Knee Arthroplasty MN Sabran, MBBS, AJM Talha*,
More informationEuropean Journal of Pain
European Journal of Pain 13 (2009) 464 471 Contents lists available at ScienceDirect European Journal of Pain journal homepage: www.europeanjournalpain.com An audit of postoperative intravenous patient-controlled
More informationProfessor Narinder Rawal, MD, PhD, FRCA (Hon), EDRA Department of Anaesthesiology and Intensive Care University Hospital Örebro, Sweden
Professor Narinder Rawal, MD, PhD, FRCA (Hon), EDRA Department of Anaesthesiology and Intensive Care University Hospital Örebro, Sweden Infiltrative techniques in perioperative pain lecture outline Why
More informationFENTANYL BY CONSTANT RATE I.V. INFUSION FOR POSTOPERATIVE ANALGESIA
Br. J. Anaesth. (1985), 5, 250-254 FENTANYL BY CONSTANT RATE I.V. INFUSION FOR POSTOPERATIVE ANALGESIA W. S. NIMMO AND J. G. TODD is a synthetic opioid analgesic 50 times more potent than morphine, with
More informationObjectives 9/7/2012. Optimizing Analgesia to Enhance the Recovery After Surgery CME FACULTY DISCLOSURE
Optimizing Analgesia to Enhance the Recovery After Surgery Francesco Carli, M.D.. McGill University, Montreal, QC, Canada. ASPMN, Baltimore, 2012 CME FACULTY DISCLOSURE Francesco Carli has no affiliation
More informationComparison Of 0.5%Bupivacaine And 0.5% Bupivacaine Plus Buprenorphine in Brachial Plexus Block
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 1 Ver. VIII (Jan. 2016), PP 01-08 www.iosrjournals.org Comparison Of 0.5%Bupivacaine And 0.5%
More informationCOMPARISON OF FENTANYL AND MORPHINE IN INTRAVENOUS PATIENT-CONTROLLED ANALGESIA AFTER OPEN GASTRECTOMY SURGERY
COMPARISON OF FENTANYL AND MORPHINE IN INTRAVENOUS PATIENT-CONTROLLED ANALGESIA AFTER OPEN GASTRECTOMY SURGERY Nguyen Toan Thang, Nguyen Huu Tu Department of Anesthesia Critical Care, Hanoi Medical University
More informationPAIN Postoperative pain after hip fracture is procedure specific
British Journal of Anaesthesia 2 (1): 111 16 (29) doi:.93/bja/aen345 PAIN Postoperative pain after hip fracture is procedure specific N. B. Foss 12 *, M. T. Kristensen 23, H. Palm 2 and H. Kehlet 4 1 Department
More informationRole and safety of epidural analgesia
Anaesthesia for Liver Resection Surgery The Association of Anaesthetists Seminars 21 Portland Place, London Thursday 15 th December 2005 Role and safety of epidural analgesia Lennart Christiansson MD,
More informationAnalgesia for ERAS programs. Dr Igor Lemech VMO Anaesthetist Wagga Wagga Base Hospital
Analgesia for ERAS programs Dr Igor Lemech VMO Anaesthetist Wagga Wagga Base Hospital Disclosure I have received honoraria from Mundipharma and MSD The new Wagga Wagga Rural Referral Centre Scope Analgesic
More information